S. Adamu

发表

Skeletal deterioration induced by RANKL infusion: a model for high-turnover bone disease

P. Kostenuik, T. Bateman, S. Morony, 2008, Osteoporosis International.

Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.

P. Kostenuik, M. Stolina, H. Ke, 2009, Bone.

Circulating amounts of osteoprotegerin and RANK ligand: genetic influence and relationship with BMD assessed in female twins.

P. Kostenuik, K. Kyvik, J. Hjelmborg, 2005, Bone.

Infrequent Delivery of a Long‐Acting PTH‐Fc Fusion Protein Has Potent Anabolic Effects on Cortical and Cancellous Bone

Steven W. Martin, P. Kostenuik, S. Morony, 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

P. Kostenuik, S. Morony, D. Lacey, 2022 .

CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin

P. Kostenuik, S. Morony, D. Lacey, 2004, Gut.

RANKL is a Marker and Mediator of Local and Systemic Bone Loss in Two Rat Models of Inflammatory Arthritis

P. Kostenuik, M. Stolina, G. Schett, 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Sustained Antiresorptive Effects After a Single Treatment With Human Recombinant Osteoprotegerin (OPG): A Pharmacodynamic and Pharmacokinetic Analysis in Rats

Steven W. Martin, P. Kostenuik, S. Morony, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy.

P. Kostenuik, S. Morony, C. Capparelli, 2005, Endocrinology.

The RANKL Inhibitor Osteoprotegerin (OPG) Causes Greater Suppression of Bone Resorption and Hypercalcemia Compared to Bisphosphonates in Two Models of Humoral Hypercalcemia of Malignancy

P. Kostenuik, S. Morony, C. Capparelli, 2005 .

INFLAMMATORY BOWEL DISEASE CD 4 + CD 45 RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin

P. Kostenuik, S. Morony, D. Danilenko, 2004 .

One Year of Transgenic Overexpression of Osteoprotegerin in Rats Suppressed Bone Resorption and Increased Vertebral Bone Volume, Density, and Strength

P. Kostenuik, M. Stolina, H. Ke, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.

P. Kostenuik, S. Morony, D. Lacey, 2006, Bone.